Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
amyloid angiopathy, cerebral
antiarrhythmic drugs
anticoagulant, contraindications
anticoagulant, treatment
arrhythmia, cardiac
atrial appendage closure
atrial cardiopathy
atrial enlargement
atrial fibrillation
atrial fibrillation, surgical treatment
atrial fibrillation, treatment
cardiac surgery
CAT scan
CAT scan, abnormal
cerebral embolism
cerebral embolism, cardiac origin
cerebral infarction
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, cryptogenic
cerebrovascular accident, etiology
cerebrovascular accident, multiple causes, coexisting
cerebrovascular accident, prevention of
cerebrovascular accident, secondary prevention
cerebrovascular accident, silent
cerebrovascular disease, risk factors in
complications
controversies in neurology
cost effectiveness
coumarin
echocardiogram
echocardiogram, transesophageal
echocardiogram, transthoracic
electrocardiogram, abnormal
embolic stroke of unknown source
embolism
embolism, air
factor Xa inhibitor
hemidiaphragm, paralysis of
INR values
intracerebral hemorrhage
intracerebral hemorrhage, familial
lacunar infarction
left atrial appendage
left atrial appendage, percutaneous closure
left atrium
mitral valve lesion
non-vitamin K antagonist oral anticoagulants
old age, neurology of
pericardial effusion
peri-procedural
phrenic nerve
phrenic nerve paralysis
prevention of neurologic disorders
radiofrequency ablation
review article
risk factors
risk-benefit assessment
safety
small vessel disease
transient ischemic attack
treatment of neurologic disorder
Watchman device
Showing articles 0 to 50 of 1005 Next >>

Spontaneous Intracerebral Hemorrhage
NEJM 388:191-192, Vandertop,W.P.,et al, 2023

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
NEJM 384:2081-2091,2154, Whitlock, R.P.,et al, 2021

Atrial Cardiopathy in Patients with Embolic Strokes of Unknown Source and Other Stroke Etiologies
Neurol 92:e288-e294, Jalini, S.,et al, 2019

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared with Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Stroke 49:1464-1470, Reddy, V.Y.,et al, 2018

Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy
Stroke 47:e190-e192, Stoker, T.B.,et al, 2016

Left Atrial Appendage Function and Stroke Risk
Stroke 46:3554-3559, Yaghi, S.,et al, 2015

Percutaneous Left Atrial Appendage Closure:Technical Aspects and Prevention of Periprocedural Complications with the Watchman Device
Workd J Cardiol 26:65-75, Mobius-Winkler,S.,et al, 2015

A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011

Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomised Non-Inferiority Trial
Lancet 374:534-542,504, Holmes,D.R.,et al, 2009

Atrial Fibrillation and Stroke
Stroke 32:803-808, Hart,R.G. &Halperin,J.L., 2001

Left Atrial Size and the Risk of Ischemic Stroke in an Ethnically Mixed Population
Stroke 30:2019-2024, DiTullio,M.R.,et al, 1999

Silent Infarcts in Patients with Ischemic Stroke are Related to Age and Size of the Left Atrium
Stroke 24:1347-1351, Mounier-Vehier,F.,et al, 1993

Enhanced Detection of Intracardiac Sources of Cerebral Emboli by Transeophageal Echocardiography
Stroke 22:734-739, Lee,R.J.,et al, 1991

A Prospective Study of Atrial Fibrillation and Stroke
Stroke 20:1648-1652, D'Olhaberriague,L.,et al, 1989

Atrial Size, Atrial Fibrillation, & Stroke
Ann Neurol 19:158-161, Caplan,L.R.,et al, 1986

Paralysis of Phrenic Nerve Due to Enlargement of Left Atrium
BMJ 288:1125, Crofton,J.,et al, 1984

Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024

Diagnostic Yield of ECG-Gated Cardiac CT in the Acute Phase of Ischemic Stroke vs Transthoracic Echocardiography
Neurol 99:e1456-e1464, Rinkel, L.A.,et al, 2022

Association of Atrial Septal Aneurysm and Shunt Size with Stroke Recurrence and Benefit From Patent Foramen Ovale Closure
JAMA Neurol 79:1175-1179, Mas,J-L.,et al, 2022

Anticoagulation after Ablation for Atrial Fibrillation
NEJM 385:466-468, Kadire, S.R., 2021

Early Ablation for Paroxysmal Atrial Fibrillation - Safety First
NEJM 384:374-375, Marine, J.E., 2021

Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021

Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020

Neurologic Deterioration after Atrial Fibrillation Ablation
Neurol 95:e1766-e1767, Narrett, J.A.,et al, 2020

Recurrent Cerebral Ischemia During Pregnancies
Neurol 95:e2453-e2457, Bulwa, Z.,et al, 2020

A 62-year-old man with history of catheter ablation presenting with recurrent strokes
Neurol 95:e3065-e3069, Jeanneret, V.,et al, 2020

May-Thurner Syndrome as a Cause of Embolic Stroke of Undetermined Source in a Young Patient
Neurol 92:e2507-e2509, De Leon-Benedetti, A.,et al, 2019

Catheter Ablation for Atrial Fibrillation
JAMA 321:1255-1257, Albert, C.M.,et al, 2019

Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018

Neurologic Abnormalities After Atrial Fibrillation Ablative Procedure
JAMA Neurol 75:1144-1145, Stanton, R.J.,et al, 2018

Complex Bilateral Corpus Callosum Infarction after Paradoxical Embolism
Neurol 91:e1947-e1948, Calheiros de Oliveira Costa, G.V.,et al, 2018

Increased Risk of Traffic Injury After a Cerebrovascular Event
Stroke 49:3006-3011, Yu, A.Y.X.,et al, 2018

Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018

PFO Closure for Cryptogenic Stroke
NEJM 378:1639-1642, Mi, M.Y.,et al, 2018

Association of Preoperatively Diagnosed Patent Foramen Ovale with Perioperative Ischemic Stroke
JAMA 319:452-462,446, Ng, P.Y.,et al, 2018

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
NEJM 376:1627-1636, Calkins, H.,et al, 2017

Cardiac Magnetic Resonance Imaging: A New Tool to Identify Cardioaortic Sources in Ischaemic Stroke
JNNP 88:31-37, Yaghi, S.,et al, 2017

A 45-year-old Woman with Right Limb Weakness
Neurol 88:e103-e107, Li, S.,et al, 2017

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017

Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017

Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016

Cardioembolic Stroke in Adults with a History of Congenital Heart Disease
Stroke 47:e79-e81, Attar, H.,et al, 2016

Clinicopathologic Conference, Acute Ischemic Stroke, Caused by Paradoxical Embolism Through a Patent Foramen Ovale, in a Patient with the May-Thurner Syndrome and a Hypercoagulable State Due to an Occult Renal-Cell Carcinoma
NEJM 374:1671-1680, Case 13-2016, 2016

Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016

The Value of Transesophageal Echocardiography for Embolic Strokes of Undetermined Source
Neuol 87:988-995, Katsanos, A.H.,et al, 2016

Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice
Front Neurol 7:1-16, Nouh, A.,et al, 2016

Stroke in Commercial Flights
Stroke 47:1117-1119, Alvarez-Velasco, R.,et al, 2016

Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015



Showing articles 0 to 50 of 1005 Next >>